Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-09-25. Active
36 1020 1068 0000 1802 0524 3920- 48 1020 1068 0000 1702 0542 7374
- 43 1020 1068 0000 1202 0363 8350
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
2 tenders recorded as contractor, with a total value of $475,016.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jan 26, 2026 | Usługa wykonania procesu biotechnologicznej produkcji peptydu penicimutide w skali półtechniczej | $166,126 | Uniwersytet Jana Kochanowskiego w Kielcach | |
| May 5, 2025 | Zakup licencji do prowadzenia prac z wykorzystaniem szczepu bakterii Lacticaseibacillus rhamnosus 72 | $308,890 | Uniwersytet Jana Kochanowskiego w Kielcach |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board acting independently is authorised to make declarations of will on behalf of the company. In the case of a multi-member management board, making declarations of will on behalf of the company requires joint action by two members of the management board or by one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Maria Olczyk Cyranowska (43) | 95 | $1,283.09 | 95% |
Others | 5 | $67.53 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Maria Olczyk-Cyranowska (43)  | Shareholder of a limited liability company, 4750.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | |
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | |
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | |
| Proper Medical Writingsp. z o.o. | $464,661.64 | propermedicalwriting.com | |
| DigitmedS.A. | $382,907.91 | digitmed.pl | |
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | |
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | |
| Wstechnologysp. z o.o. | $258,318.71 | wstechnology.pl | |
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | |
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl |
Change history
| Date | Event |
|---|---|
| 2024-04-03 | Name change (Upsale Media → Lactee Laboratories) |
| 2024-04-03 | PKD change (Removed: 62.01.Z, 62.02.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 74.90.Z; Added: 20.42.Z, 21.20.Z, 46.45.Z, 46.46.Z, 47.74.Z, 47.91.Z, 52.10.B, 68.20.Z, 72.11.Z, 77.40.Z) |
| 2020-09-09 | Entered in the register |
FAQ
Last updated: 2026-06-19